You can't study fat loss when the intervention makes subjects 30% hungrier
In the weight-loss cohort, 57.6% of participants were given dietary advice at some time point during the 4-year baseline period, 52.7% reported that they initiated a weight-loss diet, 27.0% received a weight-loss medication and 1.1% were referred for bariatric surgery (CPRD GOLD) or underwent bariatric surgery (Hospital Episode Statistics)
doi:10.1007/s12325-021-01710-0 Drug Brand Names Amantadine Gocovri Citalopram Celexa Clozapine Clozaril Escitalopram Lexapro Liraglutide Victoza, Saxenda Metformin Glucophage Naltrexone ReVia Olanzapine Zyprexa Olanzapine/samidorphan Lybalvi Phentermine Ionamin Semaglutide Rybelsus, Ozempic, Wegovy Tirzepatide Mounjaro Topiramate Topamax Zonisamide Zonegran
Not a drug, food supplement, or cosmetic
One of the most debilitating consequences of this dysregulation is neuroinflammation, which patients commonly experience as profound brain fog, cognitive impairment, and memory deficits